Vehicle theft gang busted: Police nab two, confiscate 14 tippers

Shivamogga, Aug 9: Minister of State for Railways Suresh Angadi on Saturday virtually inaugurated Malgudi Museum at Arasalu in Karantaka's Shivamogga.

The old station building at Arasalu has been converted into museum.
BJP MP from Shivamogga BY Raghavendra said that the old station building at Arasalu has been renovated keeping with 'Malgudi' theme in mind.

"It is a tribute to the makers of the popular television serial 'Malgudi Days' as the station features predominantly in the episodes which broadcast on Doordarshan in the 1980s," he said.

The museum has been designed by a famous artist John Devraj, who was the part of the serial Malgudi Days. The Mysore Divisional Railway funded the museum.

"The approach road and station area wear a new transformed look. The innovative idea of having a tea-shop in a narrow gauge coach at Arasalu station adds charm to the green surroundings," the MP said.

"Popular and internationally acclaimed serial Malgudi Days was shot here in Arasalu. The SWR Mysore division manager Aparna Garg helped to transform the station to fictional village Malgudi," he added.

The museum is about 30 km from Shivamogga city. It has steam engines and bogies besides collections of photographs hanging on the wall taken during the time of shooting for Malgudi Days.

New Delhi, Jul 28: Union Minister for Chemicals and Fertilizers Sadananda Gowda on Monday said that India has proved that it is the "pharmacy of the world" in the ongoing COVID-19 pandemic.

Speaking at a press conference here, Gowda said, "India is often referred to as 'the pharmacy of the world' and this has been proved true especially in the ongoing COVID-19 pandemic when India continued to export critical life-saving medicines to the countries."

Meanwhile, Minister of State for Chemicals and Fertilizers Mansukh Mandviya said that three bulk drug parks will be developed in the country in partnership with the states at Rs 3,000 crores.

"Three bulk drug parks will be developed in the country in partnership with the states at Rs 3,000 crores. Four medical device parks will also be developed with a government grant of Rs 100 crores for one park," Mandaviya said.

Bengaluru, Aug 2: Bengaluru based Centre for Advanced Research and Development (CARD), the research wing of organisation De scalene has come up with a device called "SHYCOCAN" (Scalene Hypercharge Corona Canon) which neutralizes the coronavirus.

Speaking to news agency Dr Rajah Vijay Kumar, Chairman, Organisation De Scalene said that the device will not kill any bacteria or fungus, however, neutralizes the coronavirus particles.

"The device was tested for its safety and efficacy and is soon going to be manufactured and marketed in the US under the Enforcement Discretion policy of USFDA and in Europe as the device is CE compliant and is CE marked," said Kumar.

He also added the device will cover a volume of 10,000 cubic feet.

The device Scalene Hypercharge Corona Canon (SHYCOCAN) is intended to be used in the residential, industrial and commercial environment and is designed for active containment by attenuation of Corona family of viruses. (Laboratories de Especialidades Immunological S.A. de C.V, Virucidal Activity concludes 99.9 per cent virus elimination), Kumar asserted.

"SHYCOCAN operates on regular 110/240V - 50/60 Hz wall socket and is a plug and play device, that delivers the necessary signals to a photon mediated electrons emitters (PMEE), that produces hypercharge high-velocity electrons by photon mediation that interacts with the negative seeking S-protein of Corona family of viruses thus reducing infectivity and prevent air and surface borne transmission of corona family of viruses," said Kumar.

The device does not use any chemicals, or any other consumables and does not produce harmful ozone gas or any other substances and is completely safe for use in any environment, he added.

"The attack mechanism of the Virus starts with the initial attachment of the virion to the host cell, it is initiated by interactions between the S-protein and its receptor on the "negative" cell membrane. The sites of receptor binding domains (RBD) within the S1 region of a coronavirus S-protein vary depending on the virus. 

The S-protein/receptor interaction is the primary determinant for a coronavirus to infect a host species and governs the tissue tropism of the virus. However, the end result is the fusion and release of the viral genome into the cytoplasm," said Kumar.

He continued saying that the counter mechanism by the device SHYCOCAN is that if negative seeking is the guidance mechanism of the S- Protein, attracted by the transmembrane potential of the host cells, then breaking this mechanism would block the Coronavirus infectivity and spread.

"The device has been in use for more than a year at the S-CARD campus, the headquarters of Scalene," said Kumar.